ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” “Company”), a clinical-stage biotechnology company developing therapeutics...
Staff
SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console
Compact New Console Facilitates Performance of Telesurgeries from a Wide Range of Locations, including Physicians’ OfficesFORT LAUDERDALE, Fla., Nov. 06,...
Vivos Inc. Issues Shareholder Update Letter
Kennewick, WA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) – The Company continues to prioritize securing FDA...
Sienna Expands Retirement Portfolio in Key Ontario Market
MARKHAM, Ontario, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today...
PolyPid’s D-PLEX₁₀₀ Wins BioTech Breakthrough Award for “Therapeutics Solution of the Year”
PolyPid's Lead Candidate Recognized for Addressing Critical Unmet Need in Surgical Site Infection Prevention Following Positive Phase 3 ResultsPETACH TIKVA,...
Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results
– Private Placement Financing of Up to $105.3 Million Closed in October 2025 to Fund Operations and R&D – Sally...
RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD
Company Appoints Distinguished UCLA Oncology Surgeon to SAB, Enhancing Board’s Expertise in Surgical Oncology and Translational Oncology Research Aimed at...
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; Awarded...
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology...
Xenon to Present at Upcoming Investor Conferences
VANCOUVER, British Columbia and BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company...
Commure Partners with DRH Health to Reduce Clinician Documentation Burden with MEDITECH-Integrated Ambient AI
DRH Health to Deploy AI to Streamline Clinical Workflows Across Its Care NetworkMOUNTAIN VIEW, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE)...
Bonk, Inc. Announces Strategic Board Refresh to Align with New Corporate Vision
New Appointments Establish a Bonk-Aligned Majority on the Board of Directors, Adding Deep Expertise in DeFi, Institutional Finance, and High-Growth...
Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
SALT LAKE CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing...
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica’s updated website...
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
FLORHAM PARK, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025
LAWRENCEVILLE, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with...
Cytrellis Secures FDA Clearance for Full Body Resurfacing Using Ellacor® Micro-Coring® Technology
New indication significantly expands applications for ellacor to treat sagging skin on body areas outside of the faceWOBURN, Mass., Nov....
Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis
Innovative tools give employers, health plans, and individuals proactive ways to prevent and manage diabetes—one of the nation’s fastest-growing and...
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use...
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansionHORSHAM, Pa.,...